Augsburg is a city in south-central Germany. It is the capital of the Swabia administrative region of Bavaria, and is located at the confluence of the Wertachand Lech rivers. The population was 276,193 in 2004.

Districts

---

There are 17 districts Stadtteile in Augsburg:

• Innenstadt (inner city)
• Jakobervorstadt
• Antonsviertel
• Bärenkeller
• Bergheim (includes Neubergheim, Wellenburg, Radegundis and Fuchssiedlung)
• Firnhaberau
• Göggingen mit Schafweidsiedlung
• Hammerschmiede
• Haunstetten-Siebenbrunn (Meringerau)
• Herrenbach-Spickel
• Hochfeld
• Hochzoll
• Inningen
• Kriegshaber
• Lechhausen
• Liann Hochfeld
• Oberhausen
• Pfersee
• Universitätsviertel (University district)cat

History

---

More on [ Augsburg ]

Germany News

Tarantino's take on WWII draws fire in Germany
Fri, 05 Sep 2008 15:24:02 -0000
Seems you can't even be nasty to Nazis anymore. A leaked script of Quentin Tarantino's World War II drama "Inglorious Bastards" already is stirring up controversy for scenes of vengeful Americans bashing, ...
How Europe wants to reduce dependency on Russian energy - Feature
Fri, 05 Sep 2008 10:50:39 -0000
Section 9 of this week's EU summit declaration on Georgia was kept markedly short.
Denmark, Germany sign bridge treaty
Fri, 05 Sep 2008 06:04:04 -0000
The road-and-rail link across the Fehmarn strait is to be completed in 2018. In Germany, local authorities and environmentalists oppose the estimated 32 billion kroner project, calling it unnecessary and a ...
Germany to update data protection laws after scandals
Fri, 05 Sep 2008 01:42:51 -0000
German ministers agreed on Thursday to update data protection laws for the digital age in the wake of scandals showing how easily personal details can be bought on the Internet.
Merck Serono and Ablynx to jointly develop nanobodies
Thu, 04 Sep 2008 21:17:04 -0000
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that it has entered into an agreement with Ablynx, to co-discover and co-develop Nanobodies against two targets in oncology and ...
Fibrex Medical Report Positive Phase II Results for FX06
Thu, 04 Sep 2008 16:36:37 -0000
CAMBRIDGE, Mass. & VIENNA, Austria-- --Sep 2, 2008 - Fibrex Medical, a biopharmaceutical company focusing on cardiovascular and inflammatory diseases, today announced positive Phase II results for FX06, a ...

Subscribe to Germany RSS feed